Short Bio (Main titles / positions / activities)

Dr. Robert Liwski obtained his PhD in Transplantation Immunology in 1999 (Dalhousie University), MD degree in 2003 (Dalhousie University), fellowship training in Hematological Pathology in 2006 (Dalhousie University) and fellowship training in HLA in 2010 (Dr. Howard Gebel, Emory). Dr. Liwski is a Hematopathologist and Professor in the Department of Pathology at Dalhousie University in Halifax, Canada. He is also Medical Director of the HLA Laboratory at the Queen Elizabeth II Health Sciences Centre in Halifax, Medical Director of the HLA Laboratory at the Canadian Blood Services Head Office in Ottawa, and Chair of the Canadian HLA Laboratory Proficiency Testing Committee.  Dr. Liwski is a transplantation immunologist and a clinician scientist with research interests in transplantation immunology, ischemia reperfusion injury and optimization of diagnostic testing in transplantation. Dr. Liwski received the 2009 Canadian Association of Pathologists Junior Scientist Award for his research investigating the role of activated protein C in prevention of ischemia reperfusion injury and cancer metastasis. 

Patrocinadores: